Evidence map›Paper›PMID 23912772›Full record

ArticlePsychopharmacology2014

Dissociations between cognitive and motor effects of psychostimulants and atomoxetine in hyperactive DAT-KO mice.

Thomas Del'Guidice, Morgane Lemasson, Adeline Etiévant, Stella Manta, Luiz Alexandre V Magno, Guy Escoffier, François S Roman, Jean-Martin Beaulieu

Abstract read
PubMed Publisher
In one paragraph

Article in Psychopharmacology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 29 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review of rodent models of attention deficit hyperactivity disorder.Neuroscience and biobehavioral reviews · 2022
    Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Stimulation of 5-HT2C receptors improves cognitive deficits induced by human tryptophan hydroxylase 2 loss of function mutation.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2014
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Thomas Del'GuidiceDépartement de psychiatrie et de neurosciences, Faculté de médecine, Université Laval, Pavillon Ferdinand-Vandry, 1050, avenue de la Médecine, Québec City, QC, Canada.
Morgane Lemasson
Adeline Etiévant
Stella Manta
Luiz Alexandre V Magno
Guy Escoffier
François S Roman
Jean-Martin Beaulieu
Institut Universitaire en Santé Mentale de Québec · CAUniversité Laval · CAAix-Marseille Université · FRCentre National de la Recherche Scientifique · FR

Funding

Canadian Institutes of Health Research NSA 93798
6 · The paper itself

Abstract

rationalePsychostimulants such as amphetamine and methylphenidate, which target the dopamine transporter (DAT), are the most frequently used drugs for the treatment of hyperactivity and cognitive deficits in humans with attention deficit hyperactivity disorder (ADHD). While psychostimulants can increase activity in healthy subjects, they exert a "paradoxical" calming effect in humans with ADHD as well as in hyperactive mice lacking the dopamine transporter (DAT-KO mice). However, the mechanism of action of these drugs and their impact on cognition in the absence of DAT remain poorly understood.

objectivesThis study was conducted to investigate the effects of psychostimulants and noradrenergic and serotonergic drugs on cognition in DAT-KO mice and normal (WT) littermates.

methodsWe used a recently developed behavioral apparatus, the automated H-maze. The H-maze involves the consecutive learning of three different rules: delayed alternation, nonalternation, and reversal tasks.

resultsTreatment of WT animals with the psychostimulants replicated the behavior observed in untreated DAT-KO mice while "paradoxically" restoring cognitive performances in DAT-KO mice. Further investigation of the potential involvement of other monoamine systems in the regulation of cognitive functions showed that the norepinephrine transporter blocker atomoxetine restored cognitive performances in DAT-KO mice without affecting hyperactivity. In contrast, the nonselective serotonin receptor agonist 5CT, which antagonizes hyperactivity in DAT-KO mice, had no effect on cognitive functions.

conclusionsTaken together, these data allow dissociation of the locomotor and cognitive effects of ADHD drugs and suggest that the combination of DAT-KO mice with the automated H-maze can constitute a powerful experimental paradigm for the preclinical development of therapeutic approaches for ADHD.

Indexed as

AmphetamineAnalysis of VarianceAnimalsAtomoxetine HydrochlorideCentral Nervous System StimulantsCognitionDopamine Plasma Membrane Transport ProteinsDose-Response Relationship, DrugHyperkinesisMaze LearningMethamphetamineMiceMice, Inbred C57BLMotor ActivityNorepinephrinePropylaminesAmphetamineAtomoxetine HydrochlorideCentral Nervous System StimulantsDopamine Plasma Membrane Transport ProteinsMethamphetamineNorepinephrinePropylaminesSerotoninSerotonin Agents

Identifiers

PMID23912772
OpenAlexW1976902496

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.